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LETTER TO  THE  EDITOR 
Actions of Ryanodine 
Dear Sir, 
We wish to comment on two conclusions reached in the article entitled "Purified 
Ryanodine Receptor from Rabbit Skeletal Muscle Is the Calcium Release Channel of 
Sarcoplasmic Reticulum," by Smith et al. (1988). 
First,  the authors state, "However, contrary to earlier interpretations  (Cannell eC 
al., 1985; Fabiato, 1985; Sutko et al., 1985; Weir et al., 1985), we find that ryanodine 
opens the release channel,  i.e., it does not inhibit Ca release." The studies cited in 
this  statement  reported  data  obtained  using  intact  cardiac  muscle  cells  and  they 
demonstrated that the actions of ryanodine in such preparations lead to an inhibition 
of the activation-dependent release of calcium from the sarcoplasmic reticulum (SR). 
Consequently,  due  either  to  the  terminology  used  or  to  a  failure  to  distinguish 
between a  specific event observed in vitro (i.e.,  the opening of a  channel)  and the 
consequences  of this  event  in  an  intact  cell  (i.e.,  the  inhibition  of a  process,  SR 
calcium release), we believe the assessment by Smith et al. is inaccurate. 
The results reported by the cited studies are not in conflict with the observations 
of Smith  et  al.  (1988).  The  process  of SR  calcium  release  in  intact  cells  can  be 
inhibited  by  an  increase  in  SR  membrane  calcium  permeability.  As  specifically 
discussed  in  several  reports  (e.g.,  Sutko  et  al.,  1979;  Sutko  and  Willerson,  1980; 
Sutko and Kenyon,  1983;  Sutko et al.,  1985;  Ito et al.,  1986),  the diminishment of 
SR calcium release could result from several mechanisms.  For example, "...  How 
does ryanodine  affect SR calcium release? The most straightforward way is that it 
blocks a  calcium channel.  The results obtained with SR membranes are consistent 
with  such  an  effect,  but  alternative  and  indirect  mechanisms  exist"  (Sutko  et  al., 
1985).  Such  alternative  mechanisms  include  an  increased  as  well  as  a  decreased 
effiux of calcium from this organelle. Either event would result in less calcium being 
available for release by subsequent activation events. In considering this argument, it 
is  important  to  keep  in  mind  that  activation-dependent  calcium  release  in  intact 
muscle  cells  is  a  process composed of multiple  events.  Alteration  of any of these 
events could affect the final outcome of the process. 
Our  suggestions  of alternative  mechanisms  of action  for  the  inhibition  of SR 
calcium  release  by  ryanodine  were  based  on  the  seminal  work  of Fairhurst  and 
Hasselbach  (1970)  and  subsequent  experiments  demonstrating  that  ryanodine  in- 
creases  the  calcium  permeability  of  SR  membranes  in  vitro  reported  by  several 
laboratories,  including  our  own  (e.g.,  Fleischer  et  al.,  1985;  Meissner,  1986; 
Lattanzio  et  al.,  1987).  The  studies  reported  by Smith  et  al.  (1988)  confirm this 
observation  and  provide  additional  information  as  to  the  mechanisms  involved. 
Based on these findings, it is probable that this action of ryanodine, at least in part, 
explains the effects of this agent on intact muscle. 
We believe it is important to make this point, because ryanodine has become an 
important tool not only for in vitro investigations of the mechanisms of SR calcium 
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release,  but  also  for  in  situ  studies  of  the  contributions  made  by  this  event  to 
excitation-contraction  coupling.  When  interpreting  the  results  obtained  in  the 
latter, it is important  to consider the consequences  of the actions of ryanodine on 
both SR membrane permeability and the SR calcium release process. 
The  second point  is a  more  general  one  and  concerns  the  identification of the 
ryanodine-sensitive  channel  as  the  SR  calcium  release  channel.  Although  this 
suggestion  is  reasonable  based  on  the  characteristics  of  the  former  and  those 
anticipated for the latter, the evidence for this identity is, at present, circumstantial. 
This  issue will be  resolved when  we  know  the  molecular architecture  of the  triad 
junction and which spaces are connected by the ryanodine-sensitive channel in intact 
muscle  cells.  Therefore,  in  view  of  (a)  the  circumstantial  nature  of our  present 
knowledge of the channel  involved in the  final step of the  release process;  (b)  the 
existence of alternative candidates for the calcium release pathway (e.g., Gould et al., 
1987;  Brunder  et  al.,  1988;  Kovacs  et  al.,  1988);  (c)  the  possibility  that  the 
ryanodine-sensitive  channel  may  not  connect  the  interior  of  the  SR  with  the 
cytoplasmic space (cf. Moore et al.,  1984);  and  (d) the complex nature of the triad 
junction and the in situ SR calcium release process, we would suggest that an open 
mind be kept concerning this issue. 
Original version received 7 July 1988 and accepted version received 8 May 1989. 
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